| CAS登錄號 | 中文名 | 英文名 | 分子結(jié)構(gòu)式 | 分子式 | 詳情 | 供應商 |
| 23978-09-8 | 4,7,13,16,21,24-六氧-1,10-二氮雙環(huán)[8.8.8]二十六烷 | kryptofix 222; 4,7,13,16,21,24-Hexaoxa-1,10-diazabicyclo[8.8.8]-hexacosane |  | C18H36N2O6 | 詳情 | 供應商 |
| 31255-17-1 | kryptofix 33 |  | C16H34N2O6 | 詳情 | 供應商 | |
| 23978-55-4 | 1,4,10,13-四氧雜-7,16-二氮雜環(huán)十八烷; 1,10-二氮雜-18-冠醚-6 | 1,4,10,13-Tetraoxa-7,16-diazacyclooctadecane; 1,10-Diaza-18-crownether; 1,10-Diaza-18-crown-6; 1,10-Diaza-4,7,13,16-tetraoxa-18-crown-6; 1,10-Diaza-4,7,13,16-tetraoxacyclooctadecane; 1,7,10,16-Tetraoxa-4,13-diazacyclooctadecane; 2,2'-kryptofix; 4,13-Diaza-18-crown-6; 4,7,13,16-Tetraoxa-1,10-diazacyclooctadecane; 7,16-Diaza-1,4,10,13-tetraoxacyclooctadecane; 7,16-Diaza-18-crown-6; Cryptand22; Cryptand(2.2); Crytand[2,2]; Diaza crown ether 22; Diaza-18-crown-6; Kryptand[2.2]; kryptofix 22; kryptofix[2.2]; NSC 339325 |  | C12H26N2O4 | 詳情 | 供應商 |
| 31249-95-3 | 1,7-偶氮-15-冠醚-5; 1,7-偶氮-15-冠-5; 1，4，10-三噁-7，13-環(huán)十五烷 | 1,4,10-Trioxa-7,13-diazacyclopentadecane; 1,7-Diaza-15-crown-5; 1,7-Diaza-4,10,13-trioxacyclopentadecane; 4,10-Diaza-15-crown-5; 4,7,13-Trioxa-1,10-diazacyclopentadecane; 7,13-Diaza-15-crown-5; Cryptand 21; Diaza crown ether 21; kryptofix 21; NSC 339327 |  | C10H22N2O3 | 詳情 | 供應商 |
| 23978-10-1 | 1,4,7,13,16-Pentaoxa-10,19-diazacycloheneicosane; 1,13-Diaza-21-crown-7; kryptofix 23; kryptofix 3.2 |  | C14H30N2O5 | 詳情 | 供應商 | |
| 79495-97-9 | 1,4,10,13-Tetraoxa-7,16-diazacyclooctadecane,7,16-didecyl-; 1,10-Didecyl-1,10-diaza-18-crown-6; 4,13-Didecyl-1,7,10,16-tetraoxa-4,13-diazacyclooctadecane; 7,16-Didecyl-1,4,10,13-tetraoxa-7,16-diazacyclooctadecane; kryptofix 22 didecyl; kryptofix 22DD; N,N'-didecyl-1,10-diaza-18-crown-6; NSC339326 |  | C32H66N2O4 | 詳情 | 供應商 | |
| 31250-06-3 | 4,7,13,18-四氧雜-1,10-二氮雜二環(huán)[8.5.5]二十烷 | 4,7,13,18-Tetraoxa-1,10-diazabicyclo[8.5.5]eicosane; Cryptand2.1.1; Cryptand 211; Cryptate 211; kryptofix 211 |  | C14H28N2O4 | 詳情 | 供應商 |
| 69878-46-2 | 4,7,13,16,21,24-Hexaoxa-1,10-diazabicyclo[8.8.8]hexacosane,5-decyl-; 5-Decyl-4,7,13,16,21,24-Hexaoxa-1,10-diazabicyclo[8.8.8]hexacosane; Cryptand 222,C10; Cryptand 222D; Cryptand [2.2.2,C10]; D 222; kryptofix 222D; kryptofix 22D |  | C28H56N2O6 | 詳情 | 供應商 | |
| 37095-49-1 | kryptofix 111; kryptofix(R) 111; kryptofix 111; 4,10,15-TRIOXA-1,7-DIAZABICYCLO-[5,5,5]HEPTADECANE; kryptofix 111 99+% |  | C12H24N2O3 | 詳情 | 供應商 | |
| 40471-97-4 | 5,6,14,15-DIBENZO-4,7,13,16,21,24-HEXAOXA-1,10-DIAZABICYCLO[8.8.8]HEXACOSANE; 5,6,14,15-DIBENZO-4,7,13,16,21,24-HEXAOXA-1,10-DIAZABICYCLO[8.8.8]HEXACOSANE; kryptofix 222 BB; kryptofix(R) 222 BB; 6,7,9,10,17,18,20,21-octahydro-8,19-(ethanoxyethanoxyethano)-8H,19H-dibenzo[b,k][1,4,10,13,7,16]tetraoxadiazacyclooctadecine; kryptofix 222 BB 99+%; 8,19-(Ethanoxyethanoxyethano)-8H,19H-dibenzob,k1,4,10,13,7,16tetraoxadiazacyclooctadecine, 6,7,9,10,17,18,20,21-octahydro-; 5,6:14,15-Bis(2-butene-1,4-diylidene)-1,10-diaza-4,7,13,16,21,24-hexaoxabicyclo[8.8.8]hexacosane; 6,7,9,10,17,18,20,21-Octahydro-8,19-(ethanoxyethanoxyethano)-8H,19H-dibenzo[b,k][1,4,10,13,7,16]tetraoxadiazacyclooctadecine |  | C26H44N2O6 | 詳情 | 供應商 |